Press Releases

Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.

Vitalant Launches New Analytical Capabilities in Pittsburgh Lab Expansion as Part of National CGT Strategy

Tuesday, June 23, 2026

Vitalant one of the nations largest nonprofit blood and biotherapies healthcare organizations today announces the launch of expanded testing capabilities within the Vitalant Coagulation Laboratory in Pittsburgh

Pheno Therapeutics Granted FDA IND Clearance for Lead Multiple Sclerosis Therapeutic Candidate PTD802

Tuesday, June 23, 2026

Pheno Therapeutics Limited Pheno a clinical stage biotechnology company focused on the discovery and development of small molecule therapeutics for the treatment of neurological diseases today announced

Rewriting Cancer returns for second film series produced for UICC by BBC StoryWorks

Tuesday, June 23, 2026

The Union for International Cancer Control UICC is pleased to present the second series of Rewriting Cancer featuring films that explore the changing face of cancer around the world

Brooks Instrument Launches Ultra-Compact, High-Performance Mass Flow Controller

Monday, June 22, 2026

Brooks Instrument a world leader in precision fluid measurement and control technology announced the global launch of its new ultracompact AMF Series Advanced Mass Flow Controller About the size of a standard Postit Note pad it has the smallest footp...

Voro Therapeutics and Alloy Therapeutics Enter Strategic Research Collaboration to Advance Next-Generation Masked T-Cell Engager Therapeutics

Friday, June 19, 2026

Voro Therapeutics a biotechnology company developing tumoractivated biologics designed to improve the therapeutic index of immune therapies and Alloy Therapeutics a biotechnology ecosystem company dedicated

IQure Pharma Awarded Grant from The Michael J. Fox Foundation to Advance EAAT2 Program in Parkinson's Disease

Friday, June 19, 2026

IQure Pharma a clinicalstage biotech company developing firstinclass astrocytetargeted therapies designed to restore glutamate balance in CNS disorders today announced it has been awarded a research grant from The Michael

LabGenius Therapeutics and LG Chem Enter a Research Collaboration, Option and License Agreement to Develop an AI/ML-Designed Tumour-Targeting Antibody

Thursday, June 18, 2026

LabGenius Therapeutics LabGenius a drug discovery company combining machine learning ML and highthroughput experimentation to optimise therapeutic antibodies today announced a multiyear research collaboration option and

Protillion Biosciences Announces Drug Discovery Collaboration with Merck

Wednesday, June 17, 2026

Protillion Biosciences Inc a leader in labintheloop AI drug design today announced the signing of a multitarget discovery collaboration and license agreement with Merck known as MSD outside the United States and Canada

Intravacc and SynphaBase Announce Strategic Partnership to Advance Conjugate Vaccine Development

Tuesday, June 16, 2026

Intravacc a leading global contract development and manufacturing organization specializing in vaccine and biologics development and manufacturing and SynphaBase AG a Swiss contract research and development

Pelago Bioscience acquires RG Discovery and creates an integrated drug discovery partner spanning biology and chemistry

Tuesday, June 16, 2026

Pelago Bioscience a contract research organization CRO specializing in drug discovery and known for its industryleading cell target interaction assays is pleased to announce the acquisition of RG Discovery